Kazuto Yamashita Selected Research

alphaxalone (alfaxalone)

1/2021	Comparison of the anesthetic effects between 5 mg/kg of alfaxalone and 10 mg/kg of propofol administered intravenously in cats.
1/2021	The anesthetic effects of intramuscular alfaxalone in dogs premedicated with low-dose medetomidine and/or butorphanol.
7/2020	Sedative and physiological effects of alfaxalone intramuscular administration in cynomolgus monkeys (Macaca fascicularis).
6/2019	Anesthetic effect of a mixture of alfaxalone, medetomidine, and butorphanol for inducing surgical anesthesia in ICR, BALB/c, and C57BL/6 mouse strains.
3/2018	Anesthetic and cardiorespiratory effects of single-bolus intravenous alfaxalone with or without intramuscular xylazine-premedication in calves.
8/2015	Sedative effects of intramuscular alfaxalone administered to cats.
3/2015	The pharmacological effects of the anesthetic alfaxalone after intramuscular administration to dogs.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kazuto Yamashita Research Topics

Disease

8	Hypoxia (Hypoxemia) 01/2021 - 10/2002
6	Hypotension (Low Blood Pressure) 07/2020 - 10/2002
5	Pain (Aches) 01/2022 - 11/2007
4	Hypercapnia 05/2022 - 02/2013
4	Infections 03/2021 - 01/2017
4	Sepsis (Septicemia) 01/2020 - 01/2018
2	Respiratory Acidosis 05/2022 - 01/2019
2	Acidosis 05/2022 - 01/2019
2	Inflammation (Inflammations) 12/2021 - 07/2012
2	Acute Kidney Injury (Acute Renal Failure) 12/2021 - 02/2019
2	COVID-19 12/2021 - 01/2021
2	Pneumonia (Pneumonitis) 03/2021 - 01/2015
2	Endotoxemia 09/2020 - 01/2014
2	Hypothermia 07/2020 - 06/2019
2	Body Weight (Weight, Body) 09/2018 - 03/2018
2	Septic Shock (Toxic Shock Syndrome) 01/2018 - 01/2018
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 12/2021
1	Coma (Comas) 03/2021
1	Anemia 03/2021
1	Aphasia (Dysphasia) 03/2021
1	Pressure Ulcer (Bedsore) 03/2021
1	Atrophy 03/2021
1	Tremor (Tremors) 01/2021
1	Ataxia (Dyssynergia) 01/2021
1	Ventricular Fibrillation 12/2020
1	Cataract (Cataracts) 06/2020
1	Ulcer 12/2018
1	Hemorrhage 11/2018
1	Critical Illness (Critically Ill) 11/2018
1	Disseminated Intravascular Coagulation 11/2018
1	Heart Arrest (Cardiac Arrest) 03/2018
1	Tachycardia (Tachyarrhythmias) 03/2018
1	Hypertension (High Blood Pressure) 03/2018
1	Abscess 03/2017
1	Wounds and Injuries (Trauma) 07/2012
1	Postoperative Pain 07/2012
1	Cardiomyopathies (Cardiomyopathy) 05/2012
1	Takotsubo Cardiomyopathy 05/2012
1	Thinness 07/2008
1	AIDS-Related Complex (ARC) 03/2003

Drug/Important Bio-Agent (IBA)

7	alphaxalone (alfaxalone)IBA 01/2021 - 03/2015
3	Oxygen (Dioxygen)IBA 03/2021 - 01/2007
3	Dobutamine FDA LinkGeneric 01/2019 - 10/2002
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2020 - 04/2018
2	Carbon DioxideIBA 01/2019 - 03/2018
2	Sevoflurane (Ultane)FDA LinkGeneric 09/2018 - 03/2017
2	robenacoxibIBA 09/2018 - 07/2012
2	Pharmaceutical PreparationsIBA 03/2017 - 01/2017
1	Contractile ProteinsIBA 05/2022
1	pimobendanIBA 05/2022
1	CalciumIBA 05/2022
1	Interleukin-10 (Interleukin 10)IBA 12/2021
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2021
1	InterleukinsIBA 12/2021
1	C-Reactive ProteinIBA 12/2021
1	ChemokinesIBA 12/2021
1	Biomarkers (Surrogate Marker)IBA 12/2021
1	Interleukin-18 (Interleukin 18)IBA 12/2021
1	Propofol (Diprivan)FDA LinkGeneric 01/2021
1	COVID-19 VaccinesIBA 01/2021
1	Contrast MediaIBA 12/2020
1	LipopolysaccharidesIBA 09/2020
1	Hypnotics and Sedatives (Sedatives)IBA 07/2020
1	Atrial Natriuretic Factor (ANF)IBA 02/2019
1	CreatinineIBA 02/2019
1	CatecholaminesIBA 01/2019
1	Epinephrine (Adrenaline)FDA LinkGeneric 01/2019
1	ColforsinIBA 01/2019
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2019
1	AntithrombinsIBA 11/2018
1	AnticoagulantsIBA 11/2018
1	Protease Inhibitors (Protease Inhibitor)IBA 11/2018
1	Heparin (Liquaemin)FDA LinkGeneric 11/2018
1	ThrombomodulinIBA 11/2018
1	Dacarbazine (DIC)FDA LinkGeneric 11/2018
1	Methicillin (Metin)FDA Link 10/2018
1	Xylazine (Xylazin)IBA 03/2018
1	carprofen FDA Link 03/2017
1	Anesthetics (Anesthetic Agents)IBA 03/2017
1	Dopamine (Intropin)FDA LinkGeneric 03/2017
1	EndotoxinsIBA 01/2014
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 07/2012
1	Meloxicam (Mobic)FDA LinkGeneric 07/2012

Therapy/Procedure

6	Anesthesia 05/2022 - 05/2012
3	General Anesthesia 06/2020 - 11/2007
3	Critical Care (Surgical Intensive Care) 12/2018 - 01/2018
2	Perioperative Period 01/2022 - 05/2012
2	Analgesia 01/2022 - 07/2016
2	Length of Stay 03/2021 - 01/2015
2	Intermittent Positive-Pressure Ventilation 10/2002 - 10/2002
1	Positive-Pressure Respiration (Positive End-Expiratory Pressure) 05/2022
1	Phacoemulsification 06/2020
1	Renal Replacement Therapy (Therapies, Renal Replacement) 02/2019
1	Vascular Access Devices (Arterial Line) 12/2018
1	Enteral Nutrition (Feeding, Tube) 12/2018
1	Cardiopulmonary Resuscitation (CPR) 03/2018
1	Debridement 03/2017
1	Therapeutics 05/2012
1	Ambulatory Surgical Procedures (Outpatient Surgery) 05/2012
1	Corneal Transplantation (Keratoplasty) 07/2008